Theriva Biologics
TOVX
TOVX
48 hedge funds and large institutions have $15.7M invested in Theriva Biologics in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
44% less capital invested
Capital invested by funds: $27.9M → $15.7M (-$12.2M)
Holders
48
Holding in Top 10
1
Calls
$2.77M
Puts
–
Top Buyers
| 1 | +$877K | |
| 2 | +$762K | |
| 3 | +$107K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$91.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$57.3K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$345K | |
| 3 | -$171K | |
| 4 |
Millennium Management
New York
|
-$143K |
| 5 |
Squarepoint
New York
|
-$85K |